Medication-Assisted Treatment

What is MAT?

It's medication and therapy together, not one instead of the other. The medication reduces cravings and withdrawal so the physical chaos calms down enough for the counseling to actually stick, and for someone to think clearly about their life instead of just surviving the next craving.

For most people starting MAT, especially for opioid use disorder, the earliest days involve a straightforward but important process called induction — starting the medication at a low dose and adjusting upward under medical supervision until cravings and withdrawal are well controlled without over-sedation. That first stretch usually involves closer contact with a provider than the maintenance phase that follows it.

It's not a replacement addiction, and it's not "trading one drug for another," despite how often that gets said. The medications used are regulated, monitored, and don't produce the same euphoric high when taken as prescribed.

The word "assisted" in the name can undersell what's happening. For many people MAT isn't a minor supplement to the real treatment — it's the single intervention with the strongest evidence behind it for opioid use disorder specifically, more effective at keeping people alive and in recovery than counseling alone in the research literature on this condition.

What it treats

Mostly opioid use disorder and alcohol use disorder — those are the conditions with FDA-approved medications and the strongest evidence behind them. It's endorsed by SAMHSA, NIDA, and the major medical bodies as an evidence-based standard of care, not an alternative or a "crutch." Given how central opioid overdose deaths are to the current overdose crisis, treatment that keeps someone alive and stable is the whole point, not a secondary concern.

Research into medications for other substances, like stimulant use disorder, is ongoing, but nothing comparable to methadone or buprenorphine has FDA approval yet for that category — which is why MAT, as a term, is mainly associated with opioids and alcohol.

It's worth noting MAT isn't only for people at the most severe end of use. Someone earlier in opioid or alcohol use disorder, with a shorter history, can still be a good candidate — waiting until things are at their worst isn't a requirement, and earlier treatment is generally easier and safer than treatment started later.

How MAT works in the brain

Opioid and alcohol use disorder both involve real, physical changes to brain chemistry — the reward system gets hijacked, and withdrawal isn't just discomfort, it's the brain demanding the substance back. MAT medications work by occupying or moderating the same receptor systems, but in a controlled, steady way that stops the cycle of crash and craving instead of feeding it. Unlike the sharp spike and crash of illicit opioid use, a properly dosed maintenance medication produces a flat, steady level in the body — no high, no crash, just enough to keep withdrawal and craving from taking over.

That steadiness is the whole point. Without it, cravings and withdrawal symptoms can dominate someone's attention so completely that therapy, work, or relationships barely have room to matter. MAT clears enough of that physical noise for the rest of recovery to actually happen.

This is part of why willpower alone is a poor predictor of who recovers from opioid or alcohol use disorder. The brain changes involved are physical, not a matter of character, and treating them with medication is closer to treating high blood pressure with a prescription than it is to "giving in." Framing it that way tends to reduce a lot of the shame that keeps people from starting MAT in the first place.

The medications

There isn't one MAT medication — there are several, treating two different conditions, and they work in meaningfully different ways.

Is MAT safe?

Used as prescribed and monitored by a provider, MAT medications are considered safe and are the standard of care for opioid and alcohol use disorder. Methadone and buprenorphine both carry real risk if combined with alcohol, benzodiazepines, or taken outside of medical supervision — which is exactly why methadone is dispensed at licensed clinics and buprenorphine requires an authorized prescriber.

The risk of staying on untreated opioid or alcohol use disorder is generally far higher than the risk of properly supervised MAT — relapse, overdose, and the medical dangers of ongoing heavy use don't go away just because someone avoids medication.

Side effects exist, as with any medication — methadone and buprenorphine can cause constipation, sweating, or sleep changes for some people; naltrexone can cause nausea early on; disulfiram requires strict avoidance of alcohol in any form, including some cooking wine and mouthwash, since the reaction can be severe. A provider should walk through the specific profile of whichever medication is being considered, not just prescribe and move on.

Naloxone: the safety net for opioid MAT

Naloxone reverses an opioid overdose in real time and is a standard safety recommendation for anyone in or around opioid treatment — including MAT patients, their families, and household members. Many programs provide naloxone directly or point patients to where they can get it, often at no cost through community programs.

Having naloxone on hand isn't a sign of distrust in the treatment plan. It's a basic safety measure, the same way a smoke detector isn't an insult to your cooking.

This matters especially for periods of higher overdose risk: right after starting MAT before the medication has fully stabilized, during any lapse in taking methadone or buprenorphine, and especially right after tapering off, when tolerance has dropped. Family members and household members are encouraged to know how to use naloxone too, not just the person in treatment.

Naloxone comes in a few forms, including a nasal spray that requires no training beyond reading the instructions on the box. Many pharmacies carry it over the counter, and some states and community organizations distribute it free of charge — cost or a prescription requirement generally isn't the barrier it used to be.

MAT combined with counseling: why both matter

Medication addresses the physical side — cravings, withdrawal, the biological pull — but it doesn't undo the habits, relationships, and thought patterns that built up around active addiction. Counseling, whether individual therapy, group sessions, or an IOP-level program, is where that other work happens.

The research consistently shows MAT works best combined with some form of behavioral treatment, not medication alone. That doesn't mean intensive therapy is mandatory for MAT to help at all — some effective programs are medication-forward with lighter counseling — but a total absence of any counseling or support is a weaker version of the model.

In practice this often looks like MAT layered on top of one of the other levels of care described elsewhere on this site — someone on buprenorphine attending IOP, or someone on naltrexone doing weekly individual therapy. The medication and the level of care aren't competing choices; they're usually meant to work together.

How much counseling is "enough" isn't a fixed number, and it's reasonable to ask a program directly what their counseling model actually looks like before committing — some offer robust weekly therapy alongside medication management, others are closer to a medication-only clinic with brief check-ins. Both can be legitimate, but knowing which one you're signing up for matters.

Common myths about MAT

The biggest one is that it's just substituting one addiction for another. It isn't — when taken as prescribed, these medications don't produce the impairing high that the original substance did, and they're specifically designed to stabilize brain chemistry rather than hijack it.

Another myth is that MAT is a short-term fix. For plenty of people it's a long-term, even lifelong, medical treatment — the same way someone might stay on medication for diabetes or high blood pressure indefinitely. That's not failure. That's just what works for their body.

A third myth is that MAT is only for people who've hit rock bottom, or that it's a last resort after other treatment has failed. In reality it's frequently recommended as a first-line treatment, not a fallback, precisely because the evidence behind it is so strong for opioid and alcohol use disorder specifically.

Stigma around MAT also shows up inside recovery communities themselves, sometimes from well-meaning people in 12-step programs who equate any medication with not being "truly" sober. Many 12-step meetings and programs have shifted to explicitly welcome people on MAT, recognizing it as legitimate treatment rather than a disqualifier — worth knowing if that concern is holding someone back from starting.

How long does it last?

As long as it helps, and that timeline is different for everyone. Some people taper off within months once other supports are solid; others stay on maintenance medication for years, sometimes indefinitely. Both are legitimate outcomes — this is a medical decision made with a provider, not a moral one.

Stopping too early, or under pressure from someone who thinks you "should be done by now," is a well-known relapse risk. The decision to taper should come from you and your provider tracking how you're actually doing, not a calendar.

Some people switch between medications over time rather than staying on the same one indefinitely — moving from methadone to buprenorphine, for example, once daily clinic visits are no longer necessary and a more flexible option fits their life better. That's a normal part of ongoing care, not a sign the original medication failed.

What is MAT called now?

You'll increasingly see MAT referred to as MOUD — Medications for Opioid Use Disorder — or more broadly as "medications for addiction treatment." SAMHSA and other agencies have leaned into this shift partly to push back on the stigma baked into the word "assisted," as if the medication were a lesser add-on rather than genuine treatment. The terms describe the same category of care.

You may also see "MAUD" (medications for alcohol use disorder) used specifically for the alcohol-focused medications, separate from MOUD's focus on opioids. None of this terminology changes what the medications actually do — it's mostly about how the field talks about them, and which term shows up depends a lot on which agency or provider is writing.

Does insurance cover MAT?

Yes, generally — MAT is a covered benefit under most private insurance, Medicaid, and Medicare, reflecting its status as the medical standard of care rather than an optional extra. Coverage specifics, including which medications are on a plan's formulary and whether prior authorization is required, vary.

Federal parity requirements mean insurers generally can't impose stricter limits on MAT coverage than they do on comparable medical treatments, though in practice prior authorization delays and formulary restrictions still happen. If a specific medication is denied, ask the prescribing provider about the appeals process rather than assuming there's no other option.

What MAT costs

Costs vary a lot by medication and setting. Methadone clinics typically charge for daily dosing and required counseling visits; buprenorphine is usually billed like any prescription medication plus office visits; naltrexone's monthly injectable form tends to be the most expensive per dose without insurance.

Generic versions of buprenorphine and the alcohol-focused medications have brought costs down significantly compared to brand-name pricing, and manufacturer patient assistance programs sometimes reduce or eliminate cost for naltrexone's injectable form for people who qualify. It's worth asking a prescriber or pharmacy directly about generic options and assistance programs before assuming the full retail price applies.

Finding a provider

For methadone, you'll need a licensed opioid treatment program (a "methadone clinic"), since it's federally regulated and dispensed onsite. For buprenorphine, you're looking for an authorized prescriber — increasingly common in regular primary care offices, not just addiction specialty clinics. Naltrexone can be prescribed more broadly.

Filter the directory below for centers that offer MAT, and don't hesitate to ask directly which specific medications a program actually provides — not every center offers all of them.

Telehealth has also expanded access to buprenorphine prescribers significantly, particularly in areas without a nearby addiction specialist, since regulatory changes made it easier to start and continue treatment through video visits. It's a legitimate option worth asking about, especially for people in rural areas or without reliable transportation.

Whichever route someone takes, the first appointment is usually an assessment — substance use history, current health, and goals — before a specific medication is chosen. It's reasonable to come with questions of your own: what to expect the first week, what side effects to watch for, and how often follow-up visits will happen.